Přejít k obsahu
Merck
  • Aortic remodelling induced by obstructive apneas is normalized with mesenchymal stem cells infusion.

Aortic remodelling induced by obstructive apneas is normalized with mesenchymal stem cells infusion.

Scientific reports (2019-08-09)
Cira Rubies, Ana-Paula Dantas, Montserrat Batlle, Marta Torres, Ramon Farre, Gemma Sangüesa, Josep M Montserrat, Lluis Mont, Isaac Almendros, Eduard Guasch
ANOTACE

Obstructive sleep apnea syndrome (OSA) promotes aortic dilatation, increased stiffness and accelerated atherosclerosis, but the mechanisms of vascular remodelling are not known. We aimed to assess vascular remodelling, its mechanisms, and the effect of mesenchymal stem cells (MSC) infusions in a clinically relevant rat model of chronic OSA involving recurrent airway obstructions leading thoracic pressure swings and intermittent hypoxia/hypercapnia (OSA-rats). Another group of rats were placed in the same setup without air obstructions (Sham-rats) and were considered controls. Our study demonstrates that chronic, non-invasive repetitive airway obstructions mimicking OSA promote remarkable structural changes of the descending thoracic aorta such as eccentric aortic hypertrophy due to an increased wall thickness and lumen diameter, an increase in the number of elastin fibers which, in contrast, get ruptured, but no changes in tunica media fibrosis. As putative molecular mechanisms of the OSA-induced vascular changes we identified an increase in reactive oxygen species and renin-angiotensin system markers and an imbalance in oxide nitric synthesis. Our results also indicate that MSC infusion blunts the OSA-related vascular changes, most probably due to their anti-inflammatory properties.